Clinical Guidelines on the Use of Assisted Reproductive Technology During Covid-19 Pandemic: A Minireview of the Current Literature

Sabetian, Soudabeh; Namavar Jahromi, Bahia; Feiz, Farnia; Castiglioni, Isabella; Cava, Claudia; Vakili, Sina

doi:10.30476/jhsss.2021.92214.1322

Document Type : Review Articles

Authors

¹ Infertility Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

² Department of Obstetrics and Gynecology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

³ Department of Radiology, Weill Cornell Medicine, NY

⁴ Department of Physics “Giuseppe Occhialini”, University of Milan-Bicocca Piazza dell’Ateneo Nuovo, 20126 Milan, Italy

⁵ Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Via F.Cervi 93, Segrate, 20090 Milan, Italy

https://doi.org/10.30476/jhsss.2021.92214.1322

Abstract

Background: The coronavirus disease-2019 (COVID-19), caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is now spread worldwide. Therefore, informative and reliable data related to the exact effects of COVID-19 on fertility and pregnancy is still of great interest until the pandemic is declared over. General guidelines regarding the protection and management of COVID-19 have been published and new information will continue to be updated daily.
Methods: In this review, we summarized clinical health guidelines for reproductive and infertility centers to improve quality management in assisted reproductive technology and minimize the potentially harmful consequences of COVID-19 on pregnancy and fertility.
Results: As specified in the literature, protocols consist of five categories, including protocols for couples, protocols for women, protocols for men, labor and delivery, and postpartum and breastfeeding.
Conclusion: General protocols for patients and staff may vary depending on specific conditions. However, this review provides some rules to ensure their safety against the disease during the pandemic.

Keywords

References

1. Akbari H, Tabrizi R, Lankarani KB, Aria H, Vakili S, Asadian F, et al. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Life sciences. 2020:118167.

2. Vakili S, Roshanisefat S, Ghahramani L, Jamalnia S. A Report of an Iranian COVID-19 Case in a Laparoscopic Cholecystectomy Patient: A Case Report and Insights. Journal of Health Sciences & Surveillance System. 2021;9(2):135-9.

3. Vakili S, Savardashtaki A, Jamalnia S, Tabrizi R, Nematollahi MH, Jafarinia M, et al. Laboratory findings of COVID-19 infection are conflicting in different age groups and pregnant women: a literature review. Archives of medical research. 2020;51(7):603-7.

4. Vakili S, Akbari H, Jamalnia S. Clinical and Laboratory findings on the differences between h1n1 influenza and coronavirus disease-2019 (covid-19): focusing on the treatment approach. Clinical Pulmonary Medicine. 2020;27(4):87-93.

5. World Health Organization, WHO (2021, Agust 20): https://www.who.int/emergencies/diseases/novel-coronavirus-2019.

6. https://www.cdc.gov/coronavirus/2019-ncov.

7. Kotlyar AM, Grechukhina O, Chen A, Popkhadze S, Grimshaw A, Tal O, et al. Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology. 2020.

8. Organization WH. Clinical management of severe acute respiratory infection (‎‎ SARI)‎‎ when COVID-19 disease is suspected: interim guidance, 13 March 2020. World Health Organization; 2020.

9. Di Mascio D, Khalil A, Saccone G, Rizzo G, Buca D, Liberati M, et al. Outcome of Coronavirus spectrum infections (SARS, MERS, COVID 1-19) during pregnancy: a systematic review and meta-analysis. American journal of obstetrics & gynecology MFM. 2020:100107.

10. Vaiarelli A, Bulletti C, Cimadomo D, Borini A, Alviggi C, Ajossa S, et al. COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine. Reproductive BioMedicine Online. 2020.

11. Rodriguez‐Wallberg KA, Wikander I. A global recommendation for restrictive provision of fertility treatments during the COVID‐19 pandemic. Acta Obstetricia et Gynecologica Scandinavica. 2020.

12. Turocy JM, Robles A, Hercz D, D'Alton M, Forman EJ, Williams Z. THE EMOTIONAL IMPACT OF THE ASRM GUIDELINES ON FERTILITY PATIENTS DURING THE COVID-19 PANDEMIC. medRxiv. 2020.

13. European Society of Human Reproduction and Embryology, ESHRE ttps://www.eshre.eu/Press-Room/ESHRE-News (2020, October 21st).

14. La Marca A, Niederberger C, Pellicer A, Nelson SM. COVID-19: lessons from the Italian reproductive medical experience. Fertility and sterility. 2020;113(5):920.

15. Mullins E, Evans D, Viner R, O'Brien P, Morris E. Coronavirus in pregnancy and delivery: rapid review. Ultrasound in Obstetrics & Gynecology. 2020;55(5):586-92.

16. Hughes L. Coronavirus (COVID-19) and Pregnancy: What Maternal-Fetal Medicine Subspecialists Need to Know. Washington, DC: The Society for Maternal-Fetal Medicine. 2020.

17. Kwiatkowski S, Borowski D, Kajdy A, Poon LC, Rokita W, Wielgos M. Why we should not stop giving aspirin to pregnant women during the COVID‐19 pandemic. Ultrasound in Obstetrics & Gynecology. 2020;55(6):841-3.

18. McIntosh JJ. Corticosteroid guidance for pregnancy during COVID-19 pandemic. American journal of perinatology. 2020;37(8):809.

19. Abobaker A, Raba AA. Does COVID-19 affect male fertility? World Journal of Urology. 2020:1-2.

20. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020.

21. Wang Z, Xu X. scRNA-seq profiling of human testes reveals the presence of the ACE2 receptor, a target for SARS-CoV-2 infection in spermatogonia, Leydig and Sertoli cells. Cells. 2020;9(4):920.

22. Pan F, Xiao X, Guo J, Song Y, Li H, Patel DP, et al. No evidence of SARS-CoV-2 in semen of males recovering from COVID-19. Fertility and sterility. 2020.

23. Stanley KE, Thomas E, Leaver M, Wells D. Coronavirus disease (COVID-19) and fertility: viral host entry protein expression in male and female reproductive tissues. Fertility and Sterility. 2020.

24. Meseguer M, Niederberger C, Pellicer A. Deep inside the pandemic, from inactivity to action: let´ s be ready. Fertility and Sterility. 2020.

25. Boelig RC, Manuck T, Oliver EA, Di Mascio D, Saccone G, Bellussi F, et al. Labor and delivery guidance for COVID-19. American Journal of Obstetrics & Gynecology MFM. 2020:100110.

26. Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know. American journal of obstetrics and gynecology. 2020.

27. Stanley KE, Thomas E, Leaver M, Wells D. Coronavirus disease-19 and fertility: viral host entry protein expression in male and female reproductive tissues. Fertil Steril. 2020;114(1):33-43.

Clinical Guidelines on the Use of Assisted Reproductive Technology During Covid-19 Pandemic: A Minireview of the Current Literature

References

References

Volume 10, Issue 1January 2022Pages 13-18

Volume 10, Issue 1
January 2022
Pages 13-18